Gland Pharma Ltd. logo

Gland Pharma Ltd. Gland Pharma

Gland Pharma Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.

₹ 0.00

0.00 (0.00)%

Ex-DatePurpose

21-07-2021

Quarterly Results

22-10-2021

Quarterly Results

21-01-2022

Quarterly Results

19-05-2022

Audited Results

20-07-2022

Quarterly Results

26-10-2022

Quarterly Results

23-01-2023

Quarterly Results

18-05-2023

Audited Results

18-05-2023

A.G.M.

07-08-2023

Quarterly Results

07-08-2023

06-11-2023

Quarterly Results

14-02-2024

Quarterly Results

04-11-2024

Quarterly Results

03-02-2025

Quarterly Results

20-05-2025

Audited Results & Final Dividend

05-08-2025

Quarterly Results

03-11-2025

Quarterly Results

28-01-2026

Quarterly Results

15-05-2026

Final Dividend & Audited Results

10-08-2026

Quarterly Results

06-11-2026

Quarterly Results

News

09-NOV-2026

Gland Pharma informs about appointment of chief investment officer

10:18 AM
09-NOV-2026

Gland Pharma zooms as its consolidated net profit grows 58% in Q2

The total consolidated income of the company has increased by 21.11% at Rs 1,902.64 crore for Q2FY27

09:54 AM
07-NOV-2026

Gland Pharma’s consolidated net profit grows 58% in Q2

The total consolidated income of the company has increased by 21.11% at Rs 1,902.64 crore for Q2FY27

12:14 PM
06-NOV-2026

Gland Pharma reports Profit after tax of Rs 4248.76 Mln, in the September 2026 quarter

04:59 PM
03-NOV-2026

Gland Pharma informs about press release

05:09 PM
03-NOV-2026

Gland Pharma gets USFDA’s approval for Methylprednisolone Acetate Injectable Suspension

According to IQVIA, the Methylprednisolone injection had US sales of approximately $214 million for the twelve months ending August 2026

12:52 PM
26-OCT-2026

USFDA concludes unannounced inspection at Gland Pharma’s Dundigal formulation facility

The said inspection was concluded with four Form 483 Observations

02:21 PM
01-OCT-2026

Gland Pharma informs about disclosure

10:53 AM
29-SEP-2026

Gland Pharma informs about newspaper publication

05:17 PM
02-SEP-2026

USFDA completes routine GMP inspection at Gland Pharma’s Visakhapatnam facility

The inspection was concluded with ZERO Form 483 Observations

12:26 PM
14-AUG-2026

Gland Pharma informs about appointment of chief executive officer

09:39 AM
11-AUG-2026

Gland Pharma zooms on reporting 47% jump in Q1 consolidated net profit

The total consolidated income of the company has increased by 19.09% at Rs 1,861.50 crore for Q1FY27

12:26 PM
11-AUG-2026

Gland Pharma reports 47% jump in Q1 consolidated net profit

The total consolidated income of the company has increased by 19.09% at Rs 1,861.50 crore for Q1FY27

12:00 PM
11-AUG-2026

Gland Pharma - Quaterly Results

12:00 AM
10-AUG-2026

Gland Pharma reports Profit after tax of Rs 3643.91 Mln, in the June 2026 quarter

04:20 PM
10-AUG-2026

Gland Pharma soars on executing strategic agreement with Global Pharmaceutical Company

The agreement is for the technology transfer, manufacturing and supply of a portfolio of sterile injectable products for global markets

09:26 AM
10-AUG-2026

Gland Pharma executes strategic agreement with Global Pharmaceutical Company

The agreement is for the technology transfer, manufacturing and supply of a portfolio of sterile injectable products for global markets

09:08 AM
06-AUG-2026

Gland Pharma gains on partnering with Neuland Laboratories

The company will establish a sterile manufacturing suite for APIs pertaining to microparticle depot products

10:50 AM
06-AUG-2026

Gland Pharma, Neuland Laboratories join forces for sterile API manufacturing

The company will establish a sterile manufacturing suite for APIs pertaining to microparticle depot products

10:10 AM
29-JUL-2026

Gland Pharma trades higher on getting USFDA’s approval for Sugammadex Injection

According to IQVIA, the product had US sales of approximately $1.6 billion for the twelve months ending April 2026

12:53 PM
29-JUL-2026

Gland Pharma gets USFDA’s approval for Sugammadex Injection

According to IQVIA, the product had US sales of approximately $1.6 billion for the twelve months ending April 2026

12:44 PM
29-JUL-2026

Gland Pharma informs about press release

12:22 PM
25-JUL-2026

Gland Pharma informs about board meeting

11:51 AM
02-JUN-2026

Gland Pharma informs about allotment of equity shares

05:33 PM
18-MAY-2026

Gland Pharma shines on reporting jumps 97% in Q4 consolidated net profit

The total consolidated income of the company increased by 26.23% at Rs 1,854.26 crore for Q4FY26

02:37 PM
18-MAY-2026

Gland Pharma’s consolidated net profit jumps 97% in Q4

The total consolidated income of the company increased by 26.23% at Rs 1,854.26 crore for Q4FY26

02:21 PM
16-MAY-2026

Gland Pharma informs about newspaper advertisement

12:33 PM
16-MAY-2026

Gland Pharma - Quaterly Results

12:00 AM
15-MAY-2026

Gland Pharma reports Profit after tax of Rs 4204.51 Mln, in the March 2026 quarter

04:25 PM
04-MAR-2026

Gland Pharma informs about press release

01:12 PM
04-MAR-2026

Gland Pharma gets USFDA’s tentative nod for Brimonidine Tartrate Ophthalmic Solution

The product is indicated to relieve redness of the eye

12:26 PM
18-FEB-2026

Gland Pharma informs about change in management

05:28 PM
18-FEB-2026

Gland Pharma informs about analyst meet

03:28 PM
06-FEB-2026

Gland Pharma gets USFDA’s approval for Zoledronic Acid Injection

This Product is indicated to treat Hypercalcemia of Malignancy and Multiple Myeloma and Bone Metastases of Solid Tumors

12:21 PM
29-JAN-2026

Gland Pharma - Quaterly Results

12:00 AM
28-JAN-2026

Gland Pharma reports Profit after tax of Rs 3078.47 Mln, in the December 2025 quarter

05:14 PM
08-JAN-2026

Gland Pharma rises on getting nod for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)

This product is indicated for the treatment of ocular itching associated with allergic conjunctivitis

09:55 AM
07-JAN-2026

Gland Pharma gets nod for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)

This product is indicated for the treatment of ocular itching associated with allergic conjunctivitis

04:58 PM
04-NOV-2025

Gland Pharma reports 12% rise in Q2 consolidated net profit

The consolidated total income of the company increased by 7.20% at Rs 1,571.04 crore for Q2FY26

03:28 PM
04-NOV-2025

Gland Pharma - Quaterly Results

12:00 AM
03-NOV-2025

Gland Pharma informs about outcome of board meeting

05:11 PM
03-NOV-2025

Gland Pharma reports Profit after tax of Rs 3019.95 Mln, in the September 2025 quarter

04:34 PM
17-OCT-2025

Gland Pharma informs about earnings call

06:09 PM
17-OCT-2025

Gland Pharma informs about analyst meet

06:03 PM
08-SEP-2025

Gland Pharma informs about investor meetings

04:07 PM
26-AUG-2025

Gland Pharma receives USFDA’s approval for Vasopressin in 5% Dextrose RTU Injection

According to IQVIA, the product had US sales of approximately $45 million for the twelve months ending June 2025

12:50 PM
12-AUG-2025

Gland Pharma gets USFDA’s nod for Cangrelor for Injection

The product had US sales of around $122 million for the twelve months ending June 2025

04:59 PM
12-AUG-2025

Gland Pharma gets USFDA’s approval for Norepinephrine Bitartrate

The company is the exclusive First-to-File and is eligible for 180 days of generic drug exclusivity

03:59 PM
12-AUG-2025

Gland Pharma informs about press release

03:13 PM
06-AUG-2025

Gland Pharma informs about press release

03:24 PM
06-AUG-2025

Gland Pharma shines on reporting 50% jump in Q1 consolidated net profit

The total consolidated income of the company increased by 7.57% at Rs 1563.15 crore for Q1FY26

10:10 AM
05-AUG-2025

Gland Pharma reports 50% jump in Q1 consolidated net profit

The total consolidated income of the company increased by 7.57% at Rs 1563.15 crore for Q1FY26

05:45 PM
05-AUG-2025

Gland Pharma - Quaterly Results

04:25 PM
05-AUG-2025

Gland Pharma - Quaterly Results

04:25 PM
05-AUG-2025

Gland Pharma - Quaterly Results

04:25 PM
05-AUG-2025

Gland Pharma reports Profit after tax of Rs 2692.58 Mln, in the June 2025 quarter

04:25 PM
31-JUL-2025

Gland Pharma informs about BRSR

05:22 PM
14-JUL-2025

Gland Pharma gains on getting GMP Compliance Certificate for Pashamylaram facility

The company has received certificate of GMP for aseptically prepared Powder for injection, infusion and inhalation

10:33 AM
14-JUL-2025

Gland Pharma gets GMP Compliance Certificate for Pashamylaram facility

The company has received certificate of GMP for aseptically prepared Powder for injection, infusion and inhalation

10:12 AM
24-JUN-2025

Gland Pharma soars on getting EIR from USFDA for Visakhapatnam facility

The said inspection was conducted between February 19, 2025 and February 25, 2025

12:20 PM
24-JUN-2025

Gland Pharma gets EIR from USFDA for Visakhapatnam facility

The said inspection was conducted between February 19, 2025 and February 25, 2025

12:00 PM
05-JUN-2025

Gland Pharma’s subsidiary gets 11 observations for Fontenay manufacturing facility

There will be no disruption in the manufacturing operations due to this final inspection report

10:22 AM
04-JUN-2025

Gland Pharma informs about press release

02:48 PM
04-JUN-2025

Gland Pharma submits press release

10:52 AM
04-JUN-2025

Gland Pharma inches up on getting USFDA’s approval for Angiotensin II Acetate Injection

The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), GIAPREZA of La Jolla Pharma LLC

09:30 AM
04-JUN-2025

Gland Pharma gets USFDA’s approval for Angiotensin II Acetate Injection

The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), GIAPREZA of La Jolla Pharma LLC

09:12 AM
27-MAY-2025

Gland Pharma informs about annual secretarial compliance report

05:09 PM
20-MAY-2025

Gland Pharma reports Profit after tax of Rs 2899.99 Mln, in the March 2025 quarter

04:59 PM
20-MAY-2025

Gland Pharma - Quaterly Results

04:59 PM
20-MAY-2025

Gland Pharma - Quaterly Results

04:59 PM
20-MAY-2025

Gland Pharma - Quaterly Results

04:59 PM
06-MAY-2025

Gland Pharma informs about board meeting

05:52 PM
02-MAY-2025

Gland Pharma rises on getting USFDA’s nod for Latanoprostene Bunod Ophthalmic Solution

This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension

02:54 PM
30-APR-2025

Gland Pharma gets USFDA’s nod for Latanoprostene Bunod Ophthalmic Solution

This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension

06:29 PM
24-APR-2025

Gland Pharma informs about change in contact details of RTA

04:55 PM
16-APR-2025

Gland Pharma informs about disclosure

10:19 AM
10-APR-2025

Gland Pharma informs about confirmation certificate

11:51 AM
09-APR-2025

Pharma stocks trade lower amid fears of Trump’s tariff on pharma imports

Gland Pharma is currently trading at Rs. 1383.00, down by 42.55 points or 2.98%

02:43 PM
03-APR-2025

Gland Pharma informs about press release

05:01 PM
03-APR-2025

Gland Pharma surges on receiving USFDA’s approval for Acetaminophen Injection

This product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older

12:50 PM
03-APR-2025

Gland Pharma receives USFDA’s approval for Acetaminophen Injection

This product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older

12:27 PM
27-FEB-2025

Gland Pharma jumps as USFDA concludes pre-approval inspection at Visakhapatnam facility

The said inspection was concluded with three form 483 observations

12:30 PM
25-FEB-2025

USFDA concludes pre-approval inspection at Visakhapatnam facility of Gland Pharma

The said inspection was concluded with three form 483 observations

04:27 PM
03-FEB-2025

Gland Pharma reports 7% rise in Q3 consolidated net profit

Total consolidated income of the company decreased by 8.85% at Rs 1442.55 crore for Q3FY25

06:12 PM
03-FEB-2025

Gland Pharma - Quaterly Results

05:22 PM
03-FEB-2025

Gland Pharma - Quaterly Results

05:22 PM
03-FEB-2025

Gland Pharma - Quaterly Results

05:22 PM
03-FEB-2025

Gland Pharma reports Profit after tax of Rs 2951.23 Mln, in the December 2024 quarter

05:22 PM
18-JAN-2025

Gland Pharma gets EIR from USFDA for Pashamylaram facility

USFDA has conducted inspection for Good Manufacturing Practices (GMP) at said facility between July 25, 2024 and August 02, 2024

03:01 PM
16-JAN-2025

Gland Pharma submits board meeting intimation

05:17 PM
16-JAN-2025

Gland Pharma gets EIR from USFDA for Hyderabad facility

USFDA has conducted inspection for Good Manufacturing Practices (GMP) at said facility between July 22, 2024 and July 25, 2024

02:28 PM
12-DEC-2024

Gland Pharma shines on getting USFDA’s approval for Phytonadione Injectable Emulsion

The Product is bioequivalent and therapeutically equivalent to the RLD, Vitamin K1 Injectable Emulsion USP, 10 mg/mL, of Hospira, Inc.

09:31 AM
12-DEC-2024

Gland Pharma gets USFDA’s approval for Phytonadione Injectable Emulsion

The Product is bioequivalent and therapeutically equivalent to the RLD, Vitamin K1 Injectable Emulsion USP, 10 mg/mL, of Hospira, Inc.

09:16 AM
03-DEC-2024

Gland Pharma informs about analyst meet

03:14 PM
03-DEC-2024

Gland Pharma jumps on getting USFDA’s nod for Latanoprost Ophthalmic Solution

This Product is used for the treatment of high eye pressure/intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension

11:50 AM
03-DEC-2024

Gland Pharma gets USFDA’s nod for Latanoprost Ophthalmic Solution

This Product is used for the treatment of high eye pressure/intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension

11:43 AM
03-DEC-2024

Gland Pharma informs about press release

11:00 AM
08-NOV-2024

Gland Pharma informs about analyst meet

05:29 PM
05-NOV-2024

Gland Pharma zooms despite reporting 16% fall in Q2 consolidated net profit

Consolidated total income of the company increased by 2.73% at Rs 1,465.49 crore for Q2FY25

11:35 AM
05-NOV-2024

Gland Pharma reports 16% fall in Q2 consolidated net profit

Consolidated total income of the company increased by 2.73% at Rs 1,465.49 crore for Q2FY25

11:26 AM
04-NOV-2024

Gland Pharma - Quaterly Results

05:38 PM
04-NOV-2024

Gland Pharma - Quaterly Results

05:38 PM
04-NOV-2024

Gland Pharma - Quaterly Results

05:38 PM
04-NOV-2024

Gland Pharma reports Profit after tax of Rs 2817.10 Mln, in the September 2024 quarter

05:38 PM
08-APR-2024

Gland Pharma shines on getting USFDA’s approval for Eribulin Mesylate Injection

The company expects to launch this product in the near term through its marketing partner

10:49 AM
08-APR-2024

Gland Pharma gets USFDA’s approval for Eribulin Mesylate Injection

The company expects to launch this product in the near term through its marketing partner

10:44 AM
21-FEB-2024

Gland Pharma informs about earnings call transcript

01:07 PM
14-FEB-2024

Gland Pharma - Quaterly Results

04:19 PM
14-FEB-2024

Gland Pharma reports Profit after tax of Rs 2768.05 Mln, in the December 2023 quarter

04:19 PM
14-FEB-2024

Gland Pharma - Quaterly Results

04:19 PM
14-FEB-2024

Gland Pharma - Quaterly Results

04:19 PM
18-JAN-2024

Gland Pharma informs about analyst meet

02:25 PM
07-DEC-2023

Gland Pharma informs about analyst meet

02:50 PM
24-NOV-2023

Gland Pharma informs about disclosure

11:29 AM
24-NOV-2023

Gland Pharma surges on getting EIR for Pashamylaram Facility

The Pre-Market Inspection was conducted between August 23, 2023 and August 26, 2023

11:20 AM
24-NOV-2023

Gland Pharma gets EIR for Pashamylaram Facility

The Pre-Market Inspection was conducted between August 23, 2023 and August 26, 2023

10:59 AM
22-NOV-2023

Gland Pharma informs about analyst meet

03:17 PM
16-NOV-2023

Gland Pharma moves up on getting USFDA’s tentative nod for Angiotensin II Injection

The company will launch the product with its marketing partner on receipt of final approval

11:52 AM
15-NOV-2023

Gland Pharma informs about press release

02:58 PM
15-NOV-2023

Gland Pharma gets USFDA’s tentative nod for Angiotensin II Injection

The company will launch the product with its marketing partner on receipt of final approval

12:25 PM
08-NOV-2023

Gland Pharma informs about receipt of establishment inspection report from US FDA

12:38 PM
08-NOV-2023

Gland Pharma gets EIR for VSEZ Sterile Oncology Facility

The GMP Inspection was conducted by USFDA between July 20, 2023 and July 28, 2023

12:19 PM
07-NOV-2023

Gland Pharma informs about press release

01:32 PM
06-NOV-2023

Gland Pharma - Quaterly Results

04:18 PM
06-NOV-2023

Gland Pharma - Quaterly Results

04:18 PM
06-NOV-2023

Gland Pharma - Quaterly Results

04:18 PM
06-NOV-2023

Gland Pharma reports Profit after tax of Rs 2575.27 Mln, in the September 2023 quarter

04:18 PM
28-OCT-2023

Gland Pharma informs about disclosure

03:50 PM
28-OCT-2023

Gland Pharma informs about disclosure

03:44 PM
26-SEP-2023

Gland Pharma informs about conclusion of US FDA inspection at pashamylaram facility

04:42 PM
26-SEP-2023

USFDA concludes inspection at Gland Pharma’s Pashamylaram Facility

The company has received Establishment Inspection Report

12:14 PM
20-SEP-2023

Gland Pharma informs about analyst meet

02:13 PM
20-SEP-2023

Gland Pharma informs about analyst meet

02:05 PM
28-AUG-2023

USFDA conducts inspection at Gland Pharma’s Pashamylaram Facility in Hyderabad

The company has received 2 observations on Form 483 with respect to ANDA filed for the product to be manufactured in a PEN device

10:41 AM
24-AUG-2023

Gland Pharma trades higher on the BSE

The company has received EIR for Dundigal facility

12:05 PM
24-AUG-2023

Gland Pharma gets EIR for Dundigal facility

USFDA had conducted inspection at the said manufacturing facility from July 03, 2023 to July 14, 2023

11:52 AM
07-AUG-2023

Gland Pharma reports Profit after tax of Rs 1875.82 Mln, in the June 2023 quarter

04:18 PM
07-AUG-2023

Gland Pharma - Quaterly Results

04:18 PM
31-JUL-2023

USFDA concludes GMP inspection at Gland Pharma’s Visakhapatnam facility

The inspection was concluded with (Zero) 483 observations and a classification of No Action Indicated

02:06 PM
14-JUL-2023

USFDA concludes GMP inspection at Gland Pharma’s Dundigal facility

The inspection was concluded with (1) 483 Observation

12:58 PM
28-JUN-2023

Gland Pharma informs about disclosure

05:15 PM
28-JUN-2023

USFDA concludes PAI, GMP inspection at Gland Pharma’s Pashamylaram facility

The inspection was concluded with (1) 483 observation

11:00 AM
24-MAY-2023

Gland Pharma informs about analyst meet

03:37 PM
19-MAY-2023

Gland Pharma reports 72% fall in Q4 consolidated net profit

Total consolidated income of the company decreased by 29.47% at Rs 823.95 crore for Q4FY23

12:00 PM
18-MAY-2023

Gland Pharma - Quaterly Results

05:26 PM
18-MAY-2023

Gland Pharma - Quaterly Results

05:26 PM
18-MAY-2023

Gland Pharma - Quaterly Results

05:26 PM
18-MAY-2023

Gland Pharma reports Profit after tax of Rs 792.06 Mln, in the March 2023 quarter

05:26 PM
03-MAY-2023

Gland Pharma informs about analyst meet

04:50 PM
21-MAR-2023

Gland Pharma informs about analyst meet

12:37 PM
17-MAR-2023

Gland Pharma submits analyst meet intimation

12:40 PM
09-MAR-2023

Gland Pharma informs about updates

03:06 PM
01-MAR-2023

Gland Pharma informs about analyst meet

03:20 PM
22-FEB-2023

Gland Pharma trades higher on the bourses

The company is planning to invest Rs 400 crore to expand Telangana’s existing facility

10:53 AM
21-FEB-2023

Gland Pharma jumps on planning to invest Rs 400 crore to expand Telangana’s existing facility

The expanded facility will have employment generation potential of more than 500 numbers of qualified, skilled and semi-skilled workforce to be recruited, mostly from the nearby places

02:06 PM
21-FEB-2023

Gland Pharma planning to invest Rs 400 crore to expand Telangana’s existing facility

The expanded facility will have employment generation potential of more than 500 numbers of qualified, skilled and semi-skilled workforce to be recruited, mostly from the nearby places

11:49 AM
10-FEB-2023

Gland Pharma informs about analyst meet

12:19 PM
27-JAN-2023

USFDA conducts inspection at Gland Pharma’s API Facility in Visakhapatnam

The inspection has been completed with Zero observations

04:03 PM
27-JAN-2023

Gland Pharma informs about analyst meet

03:01 PM
25-JAN-2023

Gland Pharma shines despite reporting 15% fall in Q3 consolidated net profit

Total income of the company decreased by 9.85% to Rs 999.80 crore for Q3FY23

10:39 AM
24-JAN-2023

Gland Pharma reports 15% fall in Q3 consolidated net profit

Total consolidated income of the company decreased by 9.85% to Rs 999.80 crore for Q3FY23

12:17 PM
23-JAN-2023

Gland Pharma - Quaterly Results

04:12 PM
23-JAN-2023

Gland Pharma - Quaterly Results

04:12 PM
23-JAN-2023

Gland Pharma - Quaterly Results

04:12 PM
04-JAN-2023

Gland Pharma trades higher on the BSE

The company has receivied EIR from US FDA for Dundigal Facility at Hyderabad

02:10 PM
04-JAN-2023

Gland Pharma receives EIR from US FDA for Dundigal Facility at Hyderabad

Earlier, the Pre-Market Inspection covering US FDA’s Quality System/Current Good Manufacturing Practice regulations for Medical Devices (21 CFR Part 820) was conducted between August 22-25, 2022

12:21 PM
30-DEC-2022

Gland Pharma informs about trading window closure

04:27 PM
26-DEC-2022

Gland Pharma informs about investors meeting

12:29 PM
12-DEC-2022

Gland Pharma informs about analyst meet intimation

05:06 PM
05-DEC-2022

Gland Pharma informs about analyst meet

12:20 PM
30-NOV-2022

Gland Pharma enters into put option agreement to acquire 100% stake in Cenexi Group

The acquisition provides Gland Pharma access to leading know-how and development capabilities in sterile forms including for ophthalmic gel, needleless injectors and hormones

10:29 AM
24-NOV-2022

Gland Pharma informs about analyst meet intimation

04:57 PM
28-OCT-2022

Gland Pharma informs about investors meet

09:27 AM
27-OCT-2022

Gland Pharma reports 20% fall in Q2 consolidated net profit

Total consolidated income of the company decreased by 1.91% at Rs 1110.03 crore for Q2FY23

02:08 PM
27-OCT-2022

Gland Pharma informs about earnings call recording

11:44 AM
26-OCT-2022

Gland Pharma - Quaterly Results

03:42 PM
26-OCT-2022

Gland Pharma - Quaterly Results

03:42 PM
20-SEP-2022

Gland Pharma informs about analyst meet

03:47 PM
12-SEP-2022

Gland Pharma informs about analyst meet

04:18 PM
09-SEP-2022

Gland Pharma informs about analyst meet

04:38 PM
06-SEP-2022

Gland Pharma informs about analyst meet

12:47 PM
26-AUG-2022

Gland Pharma informs about analyst meet

04:43 PM
21-JUL-2022

Gland Pharma informs about earrings call

09:39 AM
20-JUL-2022

Gland Pharma informs about investor presentation

05:03 PM
20-JUL-2022

Gland Pharma - Quaterly Results

03:59 PM
20-JUL-2022

Gland Pharma - Quaterly Results

03:59 PM
20-JUL-2022

Gland Pharma - Quaterly Results

03:59 PM
13-JUN-2022

Gland Pharma informs about analyst meet

04:42 PM